2020 City to Surf – Sprint for sarcoma

Sunday saw the running of the 2020 City to Surf virtual event.

While this year, we were unable to run as part of a large team as we have done in past years, CRBF was fortunate to have teams competing in many parts of Sydney.

We were truly humbled by the support, and whilst we are still yet to finalise the total figure for monies raised on the day, initial reports would suggest sarcoma research will be the big winner, with 100% of funds raised directed to the IL-23 sarcoma sub-study, at the Garvan Institute of Medical Research. https://www.trialsitenews.com/the-force-of-cooper-rice-brading-the-garvan-institute-research-in-australia-will-include-il23-in-sarcoma-clinical-trial/

Our heartfelt thanks to each of our outstanding participants who were prepared to compete, despite the miserable weather forecast.

Mark the 2021 event in your diary , and we will see you all again next year!

A new biomarker for osteosarcoma

A team of scientists led by Western Australian based scientist Dr. Emel Rothzerg – School of Biomedical Sciences at the University of The University of Western Australia, in Perth (Australia) and the Perron Institute for Neurological and Translational Science in Nedlands (Australia), reports an association between osteosarcoma and abnormal alternative splicing of the leptin receptor overlapping transcript (LEPROT). 

https://journals.sagepub.com/doi/pdf/10.1177/1535370220949139

Childhood Cancer Awareness Month


September is Childhood Cancer Awareness Month.

The Current situation at a glance.

Over 950 children and adolescents will be diagnosed with cancer each year in Australia.

One in five of these childhood cancers will be a sarcoma.

Each week, three children adolescents will die from cnacer.

Tow in five sarcoma patients will die from their disease. This increases if the cancer has spread upon diagnosis.

Childhood cancer survivors have a much higher risk of developing other malignancies later in life.

One in five sarcoma survivors will go on to develop a subsequent cancer or another sarcoma within ten years.

This month we shine the spotlight on the outstanding work of all cancer researchers, clinicians, dedicated nursing staff, treating hospitals and not for profits, whose focus is finding a cure through innovative clinical studies, improved standards of treatment and care, and funding research for childhood cancer.

It is also a time when we remember those children undergoing treatment, those yet to be diagnosed, and those who have tragically lost their lives to cancer in this country.

Sarcoma affects all ages, however it hits our young disproportionately hard.

As a dedicated sarcoma organisation, we wish to specifically highlight the outstanding work of Dr Emmy Fleuren, Senior Scientist, Zero Childhood Cancer Personalised Medicine Programme, Children’s Cancer Institute, whose research surrounding sarcoma specific high level tumour analysis stands to revolutionise the way we approach treatment for sarcoma in the future. Dr Fleuren joins her esteemed colleagues at the CCIA working tirelessly to advance a cure for all childhood cancers.

To hear more about Dr Fleuren’s remarkable Phosphoproteomics programme in our recent Let’s Talk About Sarcoma podcast series, click the link below.

We extend our heartfelt gratitude to all contributors working toward a cure for all childhood cancers.

AYA’s with cancer webinar series

Cancer Nurses Society of Australia are conducting a series of webinars for Adolescents and young adults living with cancer.

Tuesday 11 August: An introduction to cancer in the AYA population

Tuesday 8 September: Special considerations when working with AYAs with cancer

Tuesday 6 October: Discussing fertility, sexual health and other sensitive topics with AYAs with cancer. To register for these webinars, press the link below:

https://www.cnsa.org.au/events/suite/aya-cancer